Vimarsana
Biggest News Aggregation in the World

Page 5 - Nasdaq Grcl News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Grcl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Grcl Today - Breaking & Trending Today

Gracell Biotechnologies Inc. (NASDAQ:GRCL) Sees Large Increase in Short Interest - Vimarsana News

Gracell Biotechnologies Inc. (NASDAQ:GRCL) Sees Large Increase in Short Interest

Gracell Biotechnologies Inc. (NASDAQ:GRCL – Get Rating) saw a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 375,400 shares, an increase of 10.0% from the February 28th total of 341,300 shares. Currently, 0.6% of the company’s shares are sold short. Based on an average […]

Gracell Biotechnologies Inc. (NASDAQ:GRCL) Sees Significant Increase in Short Interest - Vimarsana News

Gracell Biotechnologies Inc. (NASDAQ:GRCL) Sees Significant Increase in Short Interest

Gracell Biotechnologies Inc. (NASDAQ:GRCL – Get Rating) was the recipient of a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 375,400 shares, an increase of 10.0% from the February 28th total of 341,300 shares. Currently, 0.6% of the company’s shares are short sold. Based […]

Gracell Biotechnologies' (GRCL) "Overweight" Rating Reiterated at Wells Fargo & Company - Vimarsana News

Gracell Biotechnologies' (GRCL) "Overweight" Rating Reiterated at Wells Fargo & Company

Wells Fargo & Company reissued their overweight rating on shares of Gracell Biotechnologies (NASDAQ:GRCL – Get Rating) in a report published on Monday, Benzinga reports. The firm currently has a $7.00 price target on the stock. Separately, HC Wainwright restated a buy rating and issued a $12.00 target price on shares of Gracell Biotechnologies in […]

Source: wkrb13.com
Wells Fargo & Company Reiterates "Overweight" Rating for Gracell Biotechnologies (NASDAQ:GRCL) - Vimarsana News

Wells Fargo & Company Reiterates "Overweight" Rating for Gracell Biotechnologies (NASDAQ:GRCL)

Gracell Biotechnologies (NASDAQ:GRCL – Get Rating)‘s stock had its “overweight” rating reiterated by investment analysts at Wells Fargo & Company in a report released on Monday, Benzinga reports. They currently have a $7.00 target price on the stock. Wells Fargo & Company‘s price objective would suggest a potential upside of 266.49% from the company’s previous […]

Gracell Biotechnologies to Participate in Two Upcoming - Vimarsana News

Gracell Biotechnologies to Participate in Two Upcoming

SAN DIEGO, Calif., and SUZHOU, China and SHANGHAI, China, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Gracell Biotechnologies...